Aethlon Medical Inc. (AEMD) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Aethlon Medical, Inc. on June 10, 2026. The filing serves to disclose the Company's financial results for the quarter ended March 31, 2026, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the press release (Exhibit 99.1) but are not detailed in the body of this 8-K document.
Material Changes
No specific material changes versus the prior comparable period are quantified in this filing text. The document solely announces the issuance of the Q1 2026 results.
Guidance, Outlook, and Risks
The filing incorporates the press release by reference for Item 2.02 (Results of Operations) and Item 7.01 (Regulation FD Disclosure). It explicitly states that the information in Item 7.01 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, nor subject to its liabilities. No specific guidance, outlook, or risk factors are detailed in the text of this report.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated June 10, 2026) for actual Q1 2026 financial figures.
- Verify the specific revenue and net loss numbers for the quarter ended March 31, 2026.
- Check the press release for any updated cash runway or liquidity position.
- Confirm if the press release contains any forward-looking guidance or operational milestones.